Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693938 · ClinicalTrials.gov registry record · NA
Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02693938 is a NA study that has completed, run by Yale University. The registered enrollment target is 28 participants.
The verdict
NCT02693938, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This research study is designed to look at differences in responsiveness to the subcutaneous injection of a standardized dose of rapid-acting insulin analog and blood glucose variability during different phases of the menstrual cycle in females with type 1 diabetes (T1D).
Interventions
- DEVICE Follicular Euglycemic clamp
- DEVICE Luteal Euglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2020-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02693938
The ClinicalTrials.gov registry entry for NCT02693938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Follicular Euglycemic clamp is the first listed.
NCT02693938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02693938 about?
NCT02693938 is a clinical study titled "Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes". This research study is designed to look at differences in responsiveness to the subcutaneous injection of a standardized dose of rapid-acting insulin analog and blood glucose variability during different phases of the menstrual cycle in females with type 1 diabetes (T1D).
What is the current status of trial NCT02693938?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-11-13. Estimated completion is 2020-02-07.
What interventions are being tested in trial NCT02693938?
The interventions under investigation include: Follicular Euglycemic clamp (DEVICE), Luteal Euglycemic clamp (DEVICE).
Who is sponsoring clinical trial NCT02693938?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.